CLLS: Bathi resik saben saham (EPS TTM) Cellectis SA

Logo perusahaan publik Cellectis SA (CLLS)

Cellectis S.A. is implementing robotic TALEN systems to automate drug production. The company's environmental policy is based on energy conservation and emissions filtration. Revenues currently rely on partnership contracts while drug tests are ongoing. Net income per share over the last 12 months (TTM) reflects asset dynamics, where the current value equals -0.65, helping to identify business model risks in a timely manner.

CLLS (Cellectis S.A.) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 11.11.2026

Cellectis SA - rincian analitis lan metrik utama (CLLS)

- rega saham lan prakiraan rega para ahli:
Kutipan saham Cellectis Biotherapeutics|CLLS - Konsensus nilai wajar
- informasi kapitalisasi pasar:
Kapitalisasi pasar Cellectis|CLLS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- rincian valuasi buku bisnis:
Nilai Buku saben Saham Cellectis S.A.|CLLS - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku cellectis.com|CLLS - Aset Agregat Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Cellectis S.A.|CLLS - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Cellectis Biotherapeutics|CLLS - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Cellectis|CLLS - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Cellectis S.A.|Likuiditas cepet cellectis.com
- indikator pendapatan resik lan kelipatan nilai:
CLLS - Bathi perusahaan|Proyeksi bathi mangsa ngarep Cellectis S.A.|CLLS - Kapitalisasi marang bathi|Prakiraan rega marang bathi Cellectis Biotherapeutics|CLLS - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cellectis|CLLS - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Cellectis S.A.|CLLS - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan cellectis.com|CLLS - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cellectis S.A.
Analisis umum perusahaan:cellectis.com (CLLS)
Produk seri Cellectis S.A.

This indicator measures the final net income allocated per common share over a rolling year, allowing for an assessment of real capital generation efficiency without the impact of equity dilution. By analyzing the 12-month rolling earnings per share history, an investor can determine the financial stability of Cellectis S.A. (CLLS) in the context of monetizing its licensing agreements and strategic alliances for the development of gene therapies.

Analisis perusahaan pesaing

LEGN: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku SANA (sana.com)|AUTL: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan Allogene Therapeutics, Inc.|RNAC (Cartesian Therapeutics Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Caribou Biosciences, Inc CRBU|Bathi saben saham sajrone rolas wulan pungkasan Instil Bio, Inc. (TIL)|Bathi saben saham sajrone rolas wulan pungkasan GNTA (genenta.com)|Bathi saben saham sajrone rolas wulan pungkasan Century Therapeutics, Inc. IPSC|Jasper Therapeutics Inc - Bathi saben saham sajrone rolas wulan pungkasan|SNTI: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku ADAP (Adaptimmune)|CERO: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajroning taun lumaku Alaunos Therapeutics, Inc. TCRT|ACHL (Achilles Therapeutics PLC) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan CARGO Therapeutics Inc. CRGX|Bathi saben saham sajrone rolas wulan pungkasan Poseida (PSTX)|2seventy bio, Inc - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) GRCL (Gracell Biotechnologies)